KetoSwiss

KetoSwiss

KetoSwiss

KetoSwiss develops & markets high quality exogenous ketone body therapeutics for use in disease prevention and treatment of specifically neurological diseases.
Type
B2c
Founded
2017
Follow us
Alexa global traffic share
Key People
Elena Gross
Elena Gross
Founder
Team Size
4
Employees

Product overview

the problem

Neurological diseases like migraines, dementia and alzheimer

the solution

MigraKet4 - High quality exogenous ketone bodies

target group

US, EU, Canda and Japan - migraines, dementia and alzheimer patients

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when KetoSwiss makes some noise.